PARIS] Sanofi agreed to buy UK biotech Vicebio for as much as US$1.6 billion, gaining experimental vaccines and a technology ...

Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was ...

The French pharma will pay $1.15 billion upfront to buy Vicebio and gain access to non-mRNA vaccine candidates against RSV ...

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...

A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...

French pharma giant Sanofi announced on Tuesday that it is to purchase London-based respiratory virus vaccine developer ...

Paris: Sanofi has announced it has entered into an agreement to acquire Vicebio Ltd, a privately held biotechnology company ...

The deal complements an existing partnership with Novavax that encompasses R&D of combination vaccines for Covid-19 and flu.

(Reuters) -French pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio ...

Amid its ongoing efforts to invest in mRNA technology, Sanofi said Aug. 3 it will acquire clinical-stage mRNA therapeutics company Translate Bio. The French drugmaker will acquire all outstanding ...

Decades of research contributed to successful RNA therapeutic development, beginning with scientists first demonstrating mRNA delivery into living systems. Today, mRNA technologies continue to hold ...